This commentary suggests, if we truly care about inclusion of diverse patient populations in oncology clinical trials, we build and…
Disease Categories
See MoreTop Line: First interim results of the CATNON trial demonstrated a big benefit with the…
Subscribe to Updates
Get the latest news from Quadshot.
Adjuvant nivolumab improves DFS in patients with resected esophageal cancer following neoadjuvant chemoradiation. In this…
Top Line: Can elective nodal irradiation be omitted to the pN0 neck for oral cavity…
Can immunotherapy be safely administered along with concurrent chemoradiation for head and neck cancer? We’ve…
A retrospective look at survival outcomes following post-operative radiation for 1368 resected oral cavity cancers…
This editorial suggests 2025 is finally the year to scrutinize the practice of continuing immunotherapy…
In this retrospective cohort of 13,258 patients with pancreatic cystic neoplasms, surveillance practices de-escalated substantially…
Perioperative chemo-immunotherapy with pembrolizumab improves the pathologic complete response rate and event free survival in…
We now know that there are distinct molecular classes of endometrial cancer with very different…
A population-based study of over 23 million people with cancer demonstrates the prevalence of depression…
Myxofibrosarcoma is a soft tissue sarcoma notorious for insidious growth resulting in a high likelihood…
Headline: Hypofractionation appears comparable to conventional fractionation for locally advanced head and neck cancer. The…
An analysis of the 2021 rad onc residency graduating class reports to no surprise that…
